|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 38/28 | (2006.01) |
| A61B 1/04 | (2006.01) | ||
| A61B 5/07 | (2006.01) | ||
| A61K 9/48 | (2006.01) |
| (11) | Patento numeris | 3653223 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 19203957.6 |
| Europos patento paraiškos padavimo data | 2012-06-27 | |
| (97) | Europos patento paraiškos paskelbimo data | 2020-05-20 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2021-08-25 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 201161571641 P | 2011-06-29 | US |
| (72) |
IMRAN, Mir , US
|
| (73) |
Rani Therapeutics, LLC ,
2051 Ringwood Avenue, San Jose, CA 95131,
US
|
| (54) | DEVICE FOR THE ORAL DELIVERY OF THERAPEUTIC COMPOUNDS |
| DEVICE FOR THE ORAL DELIVERY OF THERAPEUTIC COMPOUNDS |